Ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor, was shown to eliminate skin test reactivity in vivo and IgE-dependent basophil activation testing ex vivo. Blockade of the BTK pathway may represent a novel therapeutic strategy for the effective reduction of allergic reactivity.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oAxnxE
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Résumé L'extrait hydrométhanolique des parties aériennes d' Origanum glandulosum Batt. et Trab. a été étudié pour sa composition ...
-
Abstract Ethylene-octene copolymer (EOC)/organoclay nanocomposite was cured by peroxide in an internal mixer for different time periods. L...
-
Abstract Cardiomyopathy, also known as heart muscle disease, is an unfavorable condition leading to alterations in myocardial contraction ...
-
http://ift.tt/2qKmhUL
-
Abstract Understanding the spatial distribution of PM 2.5 concentration and its contributing environmental variables is critical to devel...
-
Kinematic, Kinetic and Surface Electromyography Analysis Following Zygomatic Fracture ReconstructionAbstract The surgical indications of zygomatic fracture include aesthetic and functional impairment. No standard method exists for assessi...
-
Related Articles Paolo Macchiarini's academic afterlife in Russia ends. Science. 2017 May 19;356(6339):672-673 Authors: Astakhov...
-
Abstract The molecular genetic modifications in multiple genes involved in folate and homocysteine metabolism play the pivotal role in the...
-
Respiratory Polysomnographic Findings in Patients Treated Primarily for Unilateral Cleft Lip and Palate. Cleft Palate Craniofac J. 201...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου